AE(s)	Adverse effect(s)
AKT	Protein kinase
APWV	Aortic pulse wave velocity
ATC	Anaplastic thyroid cancer
BAD	BCL2 associated agonist of cell death
CAIx	Central aortic augmentation index
c-Kit	Stem cell growth factor receptor
CV	Cardiovascular
CYP3A4	Cytochrome P4503A4
DBP	Diastolic blood pressure
DTC	Differentiated thyroid cancer
EGF	Epidermal growth factor
ERA	Endothelin receptor antagonist
ERK	Extracelluar regulated kinase
FC	Follicular cell
FGF	Fibroblast growth factor
FMTC	Familial medullary thyroid cancer
FTC	follicular thyroid cancer
GF	Growth factors
HGF	Hepatocyte growth factor
MAPK	Mitogen activated protein kinase
MEK	Methyl ethyl ketone
MET	Methionine
MDM2	Mouse double minute 2
MTC	Medullary thyroid cancer
mTOR	Mammalian rarget of rapamycin
NF-kB	Nuclear factor kappa B
OS	Overall survival
PDGF	Platelet derived growth factor
PDGFR	Platelet derived growth factor receptor
PDTC	Poorly differentiated thyroid cancer
PFS	Progression free survival
PI3K	Phosphoinositide 3 kinases
PR	Partial response
PTC	Papillary thyroid cancer
RAF	Rapidly accelerated fibrosarcoma
RAS	Rat sarcoma
RECIST	Response Evaluation Criteria in Solid Tumors
RET	Rearranged during Transfection
RTK	Receptor tyrosine kinase
SBP	Systolic blood pressure
STAT	Signal transducers and activators of transcription
TK	Tyrosine kinase
TKI	Tyrosine kinase inhibitor(s)
VEGF	Vascular endothelial growth factor
VEGFR	Vascular endothelial growth factor receptor